Table 1.
Drug (trade name) | Date of expiration/country | Company | Application area |
---|---|---|---|
Alimta® | 2016/US | Eli Lilly | Cancer |
Benicar® | 2016/US | Daiichi Sankyo | Blood pressure medication |
Benicar HTC® | 2016/US | Daiichi Sankyo | Blood pressure medication |
Crestor® | 2016/US | Astra Zeneca | Lowering LDL cholesterol |
Cubicin® | 2016/US | Merck | Bacterial infection |
Zetia® | 2016/US | Merck | Lowering LDL cholesterol |
Baraclude® | 2016/JP | Bristol–Myers Squibb | Antiviral medication (hepatitis B virus) |
Glivec® | 2016/EU | Novartis | Myeloid leukemia |
Vfend® | 2016/EU | Pfizer | Antifungal medication |
Patent expirations dates are subject to change due to patent litigation, additional patents and other market exclusivities. Patent expirations do not imply immediate generic availability